NEWSROOM

Medical Devices

BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies Reports First Quarter 2026 Financial Results

May 14, 2026

POMPANO BEACH, Fla., May 14, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026. Recent Financial and Business Highlights Generated net revenue of $6.1 million for the first quarter 2026 Progressed...

American Shared Hospital Services Reports First Quarter 2026 Financial Results

American Shared Hospital Services Reports First Quarter 2026 Financial Results

May 14, 2026

15.9% Revenue Growth Driven by Direct Patient Services Expansion; Operating Performance Improves Year-Over-Year Gross Margins Increased 36.7% Year-Over-Year Adjusted EBITDA Increased 18.4% Year-Over-Year Volumes Continuing to Trend Higher into the Second Quarter Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, May 14, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading...

SS Innovations Reports First Quarter 2026 Financial Results

SS Innovations Reports First Quarter 2026 Financial Results

May 13, 2026

Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures Fort Lauderdale, FL, May 13, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months...

BioStem Technologies to Present at the 16th Annual LD Micro Invitational

BioStem Technologies to Present at the 16th Annual LD Micro Invitational

May 12, 2026

POMPANO BEACH, Fla., May 12, 2026 PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 16th Annual LD Micro Invitational in Los Angeles, CA. BioStem Technologies to Present at the 16th Annual LD Micro Invitational...

SS Innovations Reports First Quarter 2026 Financial Results

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

May 5, 2026

Fort Lauderdale, FL, May 5, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that more than 10,500 cumulative surgeries have been successfully performed with the Company’s SSi Mantra surgical robotic system (the “SSi...

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

May 5, 2026

Expands use of Nociscan in groundbreaking trial with Roger Härtl, MD Broomfield, CO, May 05, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain and...

BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026

Apr 30, 2026

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 30,2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announces it will release its first quarter 2026 financial results on Thursday, May 14, 2026, and will host a conference call and webcast at 4:30...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Apr 30, 2026

Triple-digit annual growth signals accelerating Nociscan adoption and integration into clinical workflows Advancing reimbursement and clinical milestones, with CLARITY trial interim readout anticipated in Q4 2026 Strengthened IP footprint with new AI patent and 64 total issued and pending patents worldwide Announced $2.5 million share repurchase program Strong balance sheet, no debt and cash runway into the second half of 2027, reinforcing long-term growth strategy Broomfield, CO, April 30,...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Apr 28, 2026

Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical technologies Expansion of commercial team reflects increasing demand for Nociscan, supported by triple-digit growth in utilization BROOMFIELD, Colo., April 28, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...

SS Innovations Reports First Quarter 2026 Financial Results

SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026

Apr 23, 2026

Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL, April 23, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has unveiled its vision for...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Announces $2.5 Million Stock Repurchase Plan

Apr 22, 2026

Highlights Disciplined Capital Allocation While Supporting Continued Nociscan® Adoption Broomfield, CO, April 22, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan platform to help physicians identify the location of chronic low back pain and...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Receives Pinnacle Award for AI Innovation

Apr 14, 2026

Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market Broomfield, CO, April 14, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Announces Agreement with Weill Cornell Medicine

Apr 8, 2026

Expands use of Nociscan in groundbreaking trial Broomfield, CO, April 8, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with...

BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

Apr 8, 2026

POMPANO BEACH, Fla., April 08, 2026 PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal tissue allograft products, today announced its participation in the Symposium on Advanced Wound Care (SAWC) Spring meeting in Charlotte, NC, from April 8-12. SAWC is one of the premier gatherings for wound care professionals, clinicians,...

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

Apr 7, 2026

Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation FORT LAUDERDALE, Fla., April 07, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company is hosting the Global Multi-Specialty...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Apr 7, 2026

Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical practice Nearly 100 Nociscans performed at The London Clinic, reflecting increasing utilization for evaluation of chronic low back pain BROOMFIELD, Colo., April 07, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage...

BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 31, 2026

POMPANO BEACH, Fla., March 31, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference. BioStem’s management is scheduled to present on Monday, April 13, 2026, at 8:45 am ET....

American Shared Hospital Services Reports First Quarter 2026 Financial Results

American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 31, 2026

Announces Seven Year Extension of Proton Therapy Lease Agreement with Orlando Health Through 2033 Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, CA, March 31, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care...

BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

Mar 30, 2026

The Company continues its progression towards a Nasdaq uplisting POMPANO BEACH, FL, March 30, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its audited consolidated financial statements as of and for the fiscal years ended December 31, 2024 and...

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

Mar 30, 2026

Fort Lauderdale, FL, March 30, 2026 - PRISM MediaWire (Press Release Service - SS Innovations International, Inc.(the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has received regulatory approval for the SSi Mantra surgical robotic system (the “SSi Mantra”), for multiple indications in Colombia, Oman, Sri Lanka and...

BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 24, 2026

Strategic acquisition and strong margins help offset market pressures and position BioStem for renewed growth in 2026 POMPANO BEACH, FL, March 24, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the fourth quarter and full year ended December 31,...

American Shared Hospital Services Reports First Quarter 2026 Financial Results

American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call

Mar 24, 2026

Call Scheduled for March 31st at 12:00 PM ET SAN FRANCISCO, March 24, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care services segments, today announced that the Company will hold a conference call to discuss its fourth quarter...

BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

Mar 23, 2026

SEC-Qualified Financial Expert and Life Sciences Veteran Brings 29 Years of Accounting Leadership to the Board Pompano Beach, Fla, March 23, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Jodi Ungrodt to its Board of Directors, where she will also...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

Mar 19, 2026

BROOMFIELD, Colo., March 19, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc. (Nasdaq: ACON, ACONW) (“Aclarion” or the “Company”) today announced that its Board of Directors (the “Board”) has unanimously adopted a limited duration stockholder rights plan (the “Rights Plan”). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in...

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines

Mar 18, 2026

Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra PR Audio: Fort Lauderdale, FL, March 18, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s SSi Mantra...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

Mar 17, 2026

Broomfield, CO, March 17, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution)- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it will participate in the 38th Annual ROTH Conference, March 22-24, 2026, in Dana Point, CA. During the...

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion CEO Brent Ness to Attend LSI USA 2026

Mar 12, 2026

Broomfield, CO, March 12, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that Brent Ness, Chief Executive Officer, will be attending LSI USA 2026, one of the leading conferences of...

BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Mar 11, 2026

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., March 11, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine, today announces it will release its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026, and will host a...

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026

Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL, March 10, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and twelve months ended December...

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives

Mar 9, 2026

Financing led by Certain of the Company’s Directors and Executive Officers Fort Lauderdale, FL, March 9, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of...